Phenotypic clustering in MPZ mutations.
暂无分享,去创建一个
Richard A Lewis | Jun Li | Michael E Shy | R. Lewis | M. Shy | J. Lilien | J. Kamholz | M. Grandis | Jun Li | Á. Jáni | J. Garbern | James Y Garbern | John Kamholz | Karen Krajewski | J. Balsamo | Agnes Jáni | Marina Grandis | Rosemary R Shy | Janne Balsamo | Jack Lilien | R. Shy | K. Krajewski
[1] I. Shames,et al. Phenotypic Differences between Peripheral Myelin Protein‐22 (PMP22) and Myelin Protein Zero (P0) Mutations Associated with Charcot‐Marie‐Tooth‐Related Diseases , 2003, Journal of neuropathology and experimental neurology.
[2] G. Kraft,et al. Charcot–Marie–Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes , 2002, Neuromuscular Disorders.
[3] A. Tamaoka,et al. Corticosteroid- responsive asymmetric neuropathy with a myelin protein zero gene mutation. , 2002, Neurology.
[4] Ragnar Hanas,et al. Selection for and Initiation of Continuous Subcutaneous Insulin Infusion , 2002, Hormone Research in Paediatrics.
[5] Michael E Shy,et al. Hereditary motor and sensory neuropathies: a biological perspective , 2002, The Lancet Neurology.
[6] F. Baas,et al. Two amino-acid substitutions in the myelin protein zero gene of a case of Charcot–Marie–Tooth disease associated with light-near dissociation , 2002, Neuromuscular Disorders.
[7] J. Lupski,et al. Charcot‐Marie‐Tooth disease and related neuropathies: Mutation distribution and genotype‐phenotype correlation , 2002, Annals of neurology.
[8] M. Nakagawa,et al. Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B , 2002, Acta Neuropathologica.
[9] S. Scherer,et al. Protein Zero Is Necessary for E-Cadherin-Mediated Adherens Junction Formation in Schwann Cells , 2001, Molecular and Cellular Neuroscience.
[10] K. Zerres,et al. Phenotypic variation of a novel nonsense mutation in the P0 intracellular domain , 2001, Journal of the Neurological Sciences.
[11] M. Shy,et al. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination , 2001, The Journal of cell biology.
[12] A. Polo,et al. A somatic and germline mosaic mutation in MPZ/P0 mimics recessive inheritance of CMT1B , 2001, Neurology.
[13] G. Kuhlenbäumer,et al. Mutation analysis in Charcot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity , 2001, Journal of Neurology.
[14] P. Latour,et al. Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene , 2001, Journal of neurology, neurosurgery, and psychiatry.
[15] S. Sisodiya,et al. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation , 2000, Journal of neurology, neurosurgery, and psychiatry.
[16] A. Simonati,et al. Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero , 2000, Acta Neuropathologica.
[17] S. Hinderer,et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. , 2000, Brain : a journal of neurology.
[18] M. Shy,et al. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis , 2000, Journal of neuroscience research.
[19] V. Timmerman,et al. Charcot‐Marie‐Tooth Neuropathy Type 2 and P0 Point Mutations: Two Novel Amino Acid Substitutions (Asp61Gly; Tyr119Cys) and a Possible “Hotspot” on Thr124Met , 2000, Brain pathology.
[20] G. Sobue,et al. [Two families of Charcot-Marie-Tooth disease with Adie's pupil, axonal neuropahy and the Thr124Met mutation in the peripheral myelin protein zero gene]. , 2000, Rinshō shinkeigaku Clinical neurology.
[21] C. Lacroix,et al. The Roussy‐Lévy family: From the original description to the gene , 1999, Annals of neurology.
[22] M. Filbin,et al. Characterization of the Effect on Adhesion of Different Mutations in Myelin P0 Protein , 1999, Annals of the New York Academy of Sciences.
[23] D. Pareyson,et al. Heterozygous Null Mutation in the P0 Gene Associated with Mild Charcot‐Marie‐Tooth Disease , 1999, Annals of the New York Academy of Sciences.
[24] F. Mastaglia,et al. Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy , 1999, Journal of neurology, neurosurgery, and psychiatry.
[25] M. Shoji,et al. A novel mutation of the myelin P0 gene segregating Charcot-Marie-Tooth disease type 1B manifesting as trigeminal nerve thickening , 1999, Journal of neurology, neurosurgery, and psychiatry.
[26] P. Hawkey,et al. False negative polymerase chain reaction on cerebrospinal fluid samples in tuberculous meningitis , 1999, Journal of neurology, neurosurgery, and psychiatry.
[27] N. Wood,et al. Phenotypic variation of a new P0 mutation in genetically identical twins , 1999, Journal of Neurology.
[28] P. Latour,et al. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene , 1999, Journal of neurology, neurosurgery, and psychiatry.
[29] M. Nakagawa,et al. Germline mosaicism of MPZ Gene in Dejerine-Sottas syndrome (HMSN III) associated with hereditary stomatocytosis , 1999, Neuromuscular Disorders.
[30] A. Windebank,et al. Congenital hypomyelination due to myelin protein zero Q215X mutation , 1999, Annals of neurology.
[31] S. Sakoda,et al. A novel MPZ gene mutation in dominantly inherited neuropathy with focally folded myelin sheaths , 1999, Neurology.
[32] A. Simonati,et al. Novel mutation of the P0 extracellular domain causes a Déjérine-Sottas syndrome , 1999, Journal of neurology, neurosurgery, and psychiatry.
[33] U. Suter,et al. Impaired Intracellular Trafficking Is a Common Disease Mechanism ofPMP22Point Mutations in Peripheral Neuropathies , 1999, Neurobiology of Disease.
[34] C. van Broeckhoven,et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. , 1999, Brain : a journal of neurology.
[35] J. Mendell,et al. Effects of PMP22 duplication and deletions on the axonal cytoskeleton , 1999, Annals of neurology.
[36] F. Muntoni,et al. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene , 1998, Neurology.
[37] N. Tachi,et al. A small direct tandem duplication of the myelin protein zero gene in a patient with Dejerine-Sottas disease phenotype , 1998, Journal of the Neurological Sciences.
[38] R. Lazzarini,et al. Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher Disease , 1998, The Journal of cell biology.
[39] K. Hayasaka,et al. Novel mutation of the myelin Po gene in a pedigree with Charcot-Marie-Tooth disease type 1B. , 1997, American journal of medical genetics.
[40] A. Ohnishi,et al. De novo mutation (Arg98→Cys) of the myelin P0 gene and uncompaction of the major dense line of the myelin sheath in a severe variant of Charcot–Marie–Tooth disease type 1B , 1997, Journal of the Neurological Sciences.
[41] S. M. Sumi,et al. Clinical and pathological phenotype of the original family with Charcot‐Marie‐Tooth type 1B: A 20‐year study , 1997, Annals of neurology.
[42] A. Harding,et al. The phenotypic manifestations of chromosome 17p11.2 duplication. , 1997, Brain : a journal of neurology.
[43] D. Kirschner,et al. Inherited demyelinating peripheral neuropathies: Relating myelin packing abnormalities to P0 molecular defects , 1996 .
[44] F. Baas,et al. Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies , 1996, Annals of neurology.
[45] M. Filbin,et al. Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain , 1996, The Journal of cell biology.
[46] J. Lupski,et al. Clinical Phenotypes of Different MPZ (P0) Mutations May Include Charcot–Marie–Tooth Type 1B, Dejerine–Sottas, and Congenital Hypomyelination , 1996, Neuron.
[47] W. Hendrickson,et al. Crystal Structure of the Extracellular Domain from P0, the Major Structural Protein of Peripheral Nerve Myelin , 1996, Neuron.
[48] E. Mariman,et al. Two divergent types of nerve pathology in patients with different P sub 0 mutations in Charcot-Marie-Tooth disease , 1996, Neurology.
[49] K. Hayasaka,et al. A novel homozygous mutation of the myelin Po gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). , 1996, Biochemical and biophysical research communications.
[50] J. Eichberg,et al. Phosphorylation of myelin proteins: Recent advances , 1996, Neurochemical Research.
[51] N. Tachi,et al. A new mutation of the Po gene in patients with Charcot-Marie-Tooth disease type 1B: screening of the Po gene by heteroduplex analysis , 1996, Neuroscience Letters.
[52] D. Pham‐Dinh,et al. Charcot‐Marie‐Tooth type 1B neuropathy: third mutation of serine 63 codon in the major peripheral myelin glycoprotein P0 gene , 1995 .
[53] D. Kirschner,et al. Mutations in demyelinating peripheral neuropathies support molecular model of myelin PO‐glycoprotein extracellular domain , 1994, Journal of neuroscience research.
[54] C. van Broeckhoven,et al. Identification of a de novo insertional mutation in P0 in a patient with a Déjérine-Sottas syndrome (DSS) phenotype. , 1994, Human molecular genetics.
[55] M. Schachner,et al. Mouse P 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons , 1992, Cell.
[56] R. Martenson. Myelin: Biology and Chemistry , 1992 .
[57] S. Brady,et al. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[58] B. Trapp,et al. Role of myelin Po protein as a homophilic adhesion molecule , 1990, Nature.
[59] P. Brophy,et al. Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion, and evidence for homotypic interaction , 1990, Neuron.
[60] J. Mcleod,et al. The hypertrophic forms of hereditary motor and sensory neuropathy. A study of hypertrophic Charcot-Marie-Tooth disease (HMSN type I) and Dejerine-Sottas disease (HMSN type III) in childhood. , 1987, Brain : a journal of neurology.
[61] R. Axel,et al. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin , 1985, Cell.
[62] A. Aguayo,et al. Abnormal myelination in transplanted Trembler mouse Schwann cells , 1977, Nature.
[63] W. Demyer,et al. Pelizaeus-Merzbacher Disease , 2017 .
[64] A. Gow. Protein Misfolding as a Disease Determinant , 2004 .
[65] D. Pareyson,et al. Heterozygous null mutation in the P0 gene associated with mild Charcot-Marie-Tooth disease. , 1999, Annals of the New York Academy of Sciences.
[66] M. Filbin,et al. Characterization of the effect on adhesion of different mutations in myelin P0 protein. , 1999, Annals of the New York Academy of Sciences.
[67] M. Upadhyaya,et al. Mutation analysis in charcot‐marie‐tooth disease type 1 (CMT1) , 1998, Human mutation.
[68] K. Silander,et al. Spectrum of mutations in Finnish patients with Charcot‐Marie‐Tooth disease and related neuropathies , 1998, Human mutation.
[69] K. Hayasaka,et al. De novo mutation of the myelin Po gene in Déjérine‐Sottas disease (hereditary motor and sensory neuropathy type III): Two amino acid insertion after Asp 118 , 1998, Human mutation.
[70] M. Mostacciuolo,et al. Mutations of the same sequence of the myelin P0 gene causing two different phenotypes , 1998, Human mutation.
[71] J. Lupski,et al. Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine‐Sottas case , 1997, Human mutation.
[72] F. Muntoni,et al. Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. , 1997, Brain : a journal of neurology.
[73] J. Eichberg,et al. Phosphorylation of myelin protein: recent advances. , 1996, Neurochemical research.
[74] C. Broeckhoven,et al. A de novo duplication in 17p11.2 and a novel mutation in the Po gene in two Déjérine—Sottas syndrome patients , 1996, Human mutation.
[75] X. Estivill,et al. Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative Study , 1996, European journal of human genetics : EJHG.
[76] D. Pham‐Dinh,et al. Charcot-Marie-Tooth type 1B neuropathy: a mutation at the single glycosylation site in the major peripheral myelin glycoprotein Po. , 1996, Human mutation.
[77] D. Pham‐Dinh,et al. Charcot‐Marie‐Tooth type 1B neuropathy: A mutation at the single glycosylation site in the major peripheral myelin glycoprotein P0 , 1996 .
[78] D. Kirschner,et al. Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects. , 1996, Journal of neuroscience research.
[79] C. van Broeckhoven,et al. Mutations in the myelin protein zero gene associated with Charcot‐Marie‐Tooth disease type 1B , 1995, Human mutation.
[80] D. Pham‐Dinh,et al. Charcot-Marie-Tooth type 1B neuropathy: third mutation of serine 63 codon in the major peripheral myelin glycoprotein PO gene. , 1995, Clinical Genetics.
[81] N. Tachi,et al. De novo mutation of the myelin Po gene in Dejerine–Sottas disease (hereditary motor and sensory neuropathy type III) , 1993, Nature Genetics.
[82] J. Dymecki,et al. [Pelizaeus-Merzbacher disease]. , 1973, Neuropatologia polska.